LifePoint Health (NASDAQ:LPNT) was upgraded by BidaskClub from a “sell” rating to a “hold” rating in a research report issued on Thursday, January 11th.
Several other brokerages have also recently issued reports on LPNT. Piper Jaffray Companies reaffirmed a “hold” rating and set a $66.00 target price on shares of LifePoint Health in a research report on Wednesday, October 4th. Zacks Investment Research cut LifePoint Health from a “hold” rating to a “sell” rating in a research report on Tuesday, October 3rd. BMO Capital Markets initiated coverage on LifePoint Health in a research report on Monday, October 16th. They issued a “market perform” rating and a $59.00 price objective for the company. SunTrust Banks set a $60.00 price objective on LifePoint Health and gave the stock a “hold” rating in a research report on Thursday, October 12th. Finally, Robert W. Baird set a $69.00 price objective on LifePoint Health and gave the stock a “buy” rating in a research report on Thursday, October 12th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average price target of $59.14.
Shares of LifePoint Health (NASDAQ:LPNT) traded up $0.45 during midday trading on Thursday, reaching $48.70. The company’s stock had a trading volume of 310,679 shares, compared to its average volume of 619,675. The company has a debt-to-equity ratio of 1.24, a current ratio of 1.85 and a quick ratio of 1.65. The company has a market cap of $1,900.00, a PE ratio of 11.54, a PEG ratio of 1.14 and a beta of 0.67. LifePoint Health has a 1-year low of $42.50 and a 1-year high of $70.95.
LifePoint Health (NASDAQ:LPNT) last announced its earnings results on Friday, October 27th. The company reported $0.80 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.95 by ($0.15). The company had revenue of $1.58 billion for the quarter, compared to the consensus estimate of $1.60 billion. LifePoint Health had a net margin of 2.45% and a return on equity of 7.01%. The firm’s revenue was down .7% compared to the same quarter last year. During the same period last year, the business posted $0.94 EPS. analysts forecast that LifePoint Health will post 3.64 EPS for the current year.
LifePoint Health declared that its board has authorized a share buyback plan on Friday, October 27th that authorizes the company to buyback $200.00 million in shares. This buyback authorization authorizes the company to buy shares of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.
In other LifePoint Health news, Director Marguerite Kondracke sold 3,907 shares of LifePoint Health stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $44.73, for a total transaction of $174,760.11. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider David M. Dill sold 45,000 shares of LifePoint Health stock in a transaction dated Tuesday, January 16th. The shares were sold at an average price of $48.52, for a total value of $2,183,400.00. Following the transaction, the insider now owns 252,673 shares of the company’s stock, valued at approximately $12,259,693.96. The disclosure for this sale can be found here. Insiders have sold a total of 52,323 shares of company stock valued at $2,507,781 in the last quarter. Company insiders own 8.76% of the company’s stock.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of LifePoint Health by 1.0% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,891 shares of the company’s stock valued at $396,000 after buying an additional 56 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its stake in shares of LifePoint Health by 10.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,678 shares of the company’s stock valued at $113,000 after purchasing an additional 164 shares in the last quarter. ETRADE Capital Management LLC increased its stake in shares of LifePoint Health by 3.9% in the 2nd quarter. ETRADE Capital Management LLC now owns 6,896 shares of the company’s stock valued at $463,000 after purchasing an additional 262 shares in the last quarter. Ameritas Investment Partners Inc. increased its stake in shares of LifePoint Health by 2.6% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 12,080 shares of the company’s stock valued at $811,000 after purchasing an additional 305 shares in the last quarter. Finally, Wells Fargo & Company MN increased its stake in shares of LifePoint Health by 2.0% in the 2nd quarter. Wells Fargo & Company MN now owns 22,394 shares of the company’s stock valued at $1,504,000 after purchasing an additional 443 shares in the last quarter.
ILLEGAL ACTIVITY WARNING: This report was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.dispatchtribunal.com/2018/01/19/lifepoint-health-lpnt-upgraded-by-bidaskclub-to-hold.html.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health and related companies with MarketBeat.com's FREE daily email newsletter.